论文部分内容阅读
目的:探讨不同抗病毒方案治疗艾滋病的临床疗效及不良反应分析。方法:选取我中心2015年5月至2016年5月的艾滋病患者66例进行抗病毒试验,按照领取抗病毒药物的先后顺序分成3组,分别命名为甲乙丙组。其中甲组使用齐多夫定、拉米夫定、奈韦拉平、进行服药治疗;乙组使用替诺福韦、拉米夫定、依非韦仑进行服药治疗。对两种服药方案发生的不良反应进行对比。结果:两组患者不良反应非常少,耐受性良好,不具有统计学差异(P>0.05)。结论:通过不同的抗病毒方案治疗艾滋病均可以使患者提高自身免疫力,值得推广使用。
Objective: To investigate the clinical effects and adverse reactions of different anti-virus programs in the treatment of AIDS. Methods: Sixty-six AIDS patients from May 2015 to May 2016 in our center were tested for antiviral activity and divided into 3 groups according to the order of receiving antiviral drugs. They were named as B and C respectively. Group A was treated with zidovudine, lamivudine and nevirapine, and group B was treated with tenofovir, lamivudine and efavirenz. Adverse reactions to the two medication regimens were compared. Results: The two groups of patients with very few adverse reactions, well tolerated, there was no statistical difference (P> 0.05). Conclusion: The treatment of AIDS through different anti-virus programs can make patients improve their immunity, it is worth promoting the use of.